Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine.

Muth M, Jänsch N, Kopranovic A, Krämer A, Wössner N, Jung M, Kirschhöfer F, Brenner-Weiß G, Meyer-Almes FJ.

Biochim Biophys Acta Gen Subj. 2019 Mar;1863(3):577-585. doi: 10.1016/j.bbagen.2019.01.001. Epub 2019 Jan 3.

PMID:
30611847
2.

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial.

Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marmé F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Janni W, Muth M, Kreuzeder J, Quiering C, Grischke EM, Tesch H.

J Bone Oncol. 2018 Oct 2;14:010-10. doi: 10.1016/j.jbo.2018.09.010. eCollection 2019 Feb.

3.

The enzyme activity of histone deacetylase 8 is modulated by a redox-switch.

Jänsch N, Meyners C, Muth M, Kopranovic A, Witt O, Oehme I, Meyer-Almes FJ.

Redox Biol. 2019 Jan;20:60-67. doi: 10.1016/j.redox.2018.09.013. Epub 2018 Sep 27.

4.

Enhancing Selectivity and Kinetics in Oxidative Photocyclization by Supramolecular Control.

Haldar R, Diring S, Samanta PK, Muth M, Clancy W, Mazel A, Schlabach S, Kirschhöfer F, Brenner-Weiß G, Pati SK, Odobel F, Wöll C.

Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13662-13665. doi: 10.1002/anie.201806996. Epub 2018 Sep 19.

PMID:
30160815
5.

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.

Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marmé F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Hadji P, Janni W, Muth M, Kreuzeder J, Quiering C, Taran FA.

Int J Cancer. 2019 Feb 15;144(4):877-885. doi: 10.1002/ijc.31738. Epub 2018 Oct 30.

PMID:
29992557
6.

Food Safety Practices in the U.S. Meat Slaughter and Processing Industry: Changes from 2005 to 2015.

Viator CL, Cates SC, Karns SA, Muth MK.

J Food Prot. 2017 Aug;80(8):1384-1392. doi: 10.4315/0362-028X.JFP-16-378.

PMID:
28722483
7.

A New Molecular Mechanism To Engineer Protean Agonism at a G Protein-Coupled Receptor.

De Min A, Matera C, Bock A, Holze J, Kloeckner J, Muth M, Traenkle C, De Amici M, Kenakin T, Holzgrabe U, Dallanoce C, Kostenis E, Mohr K, Schrage R.

Mol Pharmacol. 2017 Apr;91(4):348-356. doi: 10.1124/mol.116.107276. Epub 2017 Feb 6.

PMID:
28167741
8.

Costs of Food Safety Investments in the Meat and Poultry Slaughter Industries.

Viator CL, Muth MK, Brophy JE, Noyes G.

J Food Sci. 2017 Feb;82(2):260-269. doi: 10.1111/1750-3841.13597. Epub 2017 Jan 24. Review.

PMID:
28117890
9.

Competition of Thermomyces lanuginosus lipase with its hydrolysis products at the oil-water interface.

Muth M, Rothkötter S, Paprosch S, Schmid RP, Schnitzlein K.

Colloids Surf B Biointerfaces. 2017 Jan 1;149:280-287. doi: 10.1016/j.colsurfb.2016.10.019. Epub 2016 Oct 12.

PMID:
27770698
10.

Food Safety Practices in the Egg Products Industry.

Viator CL, Cates SC, Karns SA, Muth MK, Noyes G.

J Food Prot. 2016 Jul;79(7):1210-5. doi: 10.4315/0362-028X.JFP-15-520.

PMID:
27357041
11.

Ellipsometric study of molecular orientations of Thermomyces lanuginosus lipase at the air-water interface by simultaneous determination of refractive index and thickness.

Muth M, Schmid RP, Schnitzlein K.

Colloids Surf B Biointerfaces. 2016 Apr 1;140:60-66. doi: 10.1016/j.colsurfb.2015.12.024. Epub 2015 Dec 18.

PMID:
26735895
12.

Perceived stress, unhealthy eating behaviors, and severe obesity in low-income women.

Richardson AS, Arsenault JE, Cates SC, Muth MK.

Nutr J. 2015 Dec 3;14:122. doi: 10.1186/s12937-015-0110-4.

13.

Beyond the sticker price: including and excluding time in comparing food prices.

Yang Y, Davis GC, Muth MK.

Am J Clin Nutr. 2015 Jul;102(1):165-71. doi: 10.3945/ajcn.114.101444. Epub 2015 May 20.

PMID:
25994565
14.

Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer.

Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, Baier M, Weigel MT, Wenners AS, Alkatout I, Bauer M, Jonat W, Mundhenke C.

Oncology. 2014;87(5):300-10. doi: 10.1159/000365553. Epub 2014 Aug 26.

PMID:
25171229
15.

Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study.

Hadji P, Kauka A, Ziller M, Birkholz K, Baier M, Muth M, Kann P.

Breast Cancer Res Treat. 2014 Apr;144(2):343-51. doi: 10.1007/s10549-014-2860-7. Epub 2014 Feb 12.

PMID:
24519387
16.

Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.

Hadji P, Kauka A, Ziller M, Birkholz K, Baier M, Muth M, Bauer M.

Osteoporos Int. 2014 Apr;25(4):1369-78. doi: 10.1007/s00198-013-2615-z. Epub 2014 Feb 7.

PMID:
24504100
17.

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.

Fasching PA, Jud SM, Hauschild M, Kümmel S, Schütte M, Warm M, Hanf V, Grab D, Krocker J, Stickeler E, Kreienberg R, Müller T, Kühn T, Wolf C, Kahlert S, Paepke S, Berghorn M, Muth M, Baier M, Wackwitz B, Schulz-Wendtland R, Beckmann MW, Lux MP.

BMC Cancer. 2014 Feb 5;14:66. doi: 10.1186/1471-2407-14-66.

18.

Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

Bock A, Chirinda B, Krebs F, Messerer R, Bätz J, Muth M, Dallanoce C, Klingenthal D, Tränkle C, Hoffmann C, De Amici M, Holzgrabe U, Kostenis E, Mohr K.

Nat Chem Biol. 2014 Jan;10(1):18-20. doi: 10.1038/nchembio.1384. Epub 2013 Nov 10.

PMID:
24212135
19.

Influence of charge carrier mobility and morphology on solar cell parameters in devices of mono- and bis-fullerene adducts.

Muth MA, Mitchell W, Tierney S, Lada TA, Xue X, Richter H, Carrasco-Orozco M, Thelakkat M.

Nanotechnology. 2013 Dec 6;24(48):484001. doi: 10.1088/0957-4484/24/48/484001. Epub 2013 Nov 6.

PMID:
24196215
20.

Authors' response.

Arsenault JE, Fulgoni VL 3rd, Hersey JC, Muth MK.

J Acad Nutr Diet. 2013 May;113(5):636. doi: 10.1016/j.jand.2013.03.006. No abstract available.

PMID:
23601891
21.

Frequency of fever in pediatric patients presenting to the emergency department with non-illness-related conditions.

Muth M, Statler J, Gentile DL, Hagle ME.

J Emerg Nurs. 2013 Jul;39(4):389-92. doi: 10.1016/j.jen.2012.09.018. Epub 2013 Feb 4. No abstract available.

PMID:
23380298
22.

Effects of front-of-package and shelf nutrition labeling systems on consumers.

Hersey JC, Wohlgenant KC, Arsenault JE, Kosa KM, Muth MK.

Nutr Rev. 2013 Jan;71(1):1-14. doi: 10.1111/nure.12000. Review.

PMID:
23282247
23.

The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer.

Hadji P, Ziller M, Maurer T, Autenrieth M, Muth M, Ruebel A, May C, Birkholz K, Diebel E, Gleissner J, Rothe P, Gschwend JE.

J Bone Oncol. 2012 Aug 10;1(3):88-94. doi: 10.1016/j.jbo.2012.07.002. eCollection 2012 Dec.

24.

A novel approach to selecting and weighting nutrients for nutrient profiling of foods and diets.

Arsenault JE, Fulgoni VL 3rd, Hersey JC, Muth MK.

J Acad Nutr Diet. 2012 Dec;112(12):1968-75. doi: 10.1016/j.jand.2012.08.032.

PMID:
23174684
25.

Effect of a Nutrient Rich Foods consumer education program: results from the nutrition advice study.

Glanz K, Hersey J, Cates S, Muth M, Creel D, Nicholls J, Fulgoni V 3rd, Zaripheh S.

J Acad Nutr Diet. 2012 Jan;112(1):56-63. doi: 10.1016/j.jada.2011.08.031. Epub 2011 Nov 4.

PMID:
22717177
26.

Analysis of the relationship between economic measures and Salmonella testing results in young chicken slaughter establishments.

Muth MK, Creel DV, Karns SA, Wilkus J.

J Food Prot. 2012 Mar;75(3):449-55. doi: 10.4315/0362-028X.JFP-11-319.

PMID:
22410217
27.
28.

Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs.

Jonigk D, Merk M, Hussein K, Maegel L, Theophile K, Muth M, Lehmann U, Bockmeyer CL, Mengel M, Gottlieb J, Welte T, Haverich A, Golpon H, Kreipe H, Laenger F.

Am J Pathol. 2011 Feb;178(2):599-608. doi: 10.1016/j.ajpath.2010.10.032.

29.

Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.

Hussein K, Büsche G, Muth M, Göhring G, Kreipe H, Bock O.

Ann Hematol. 2011 Mar;90(3):307-13. doi: 10.1007/s00277-010-1072-4. Epub 2010 Sep 15.

PMID:
20842500
30.

Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.

Muth M, Engelhardt BM, Kröger N, Hussein K, Schlué J, Büsche G, Kreipe HH, Bock O.

Ann Hematol. 2011 Jan;90(1):33-40. doi: 10.1007/s00277-010-1024-z. Epub 2010 Jul 13.

PMID:
20625903
31.

Aberrant proplatelet formation in chronic myeloproliferative neoplasms.

Muth M, Büsche G, Bock O, Hussein K, Kreipe H.

Leuk Res. 2010 Nov;34(11):1424-9. doi: 10.1016/j.leukres.2010.03.040. Epub 2010 Apr 28.

PMID:
20430444
32.

Epiphyte loads on seagrasses and microphytobenthos abundance are not reliable indicators of nutrient availability in oligotrophic coastal ecosystems.

Fourqurean JW, Muth MF, Boyer JN.

Mar Pollut Bull. 2010 Jul;60(7):971-83. doi: 10.1016/j.marpolbul.2010.03.003. Epub 2010 Apr 8.

PMID:
20381091
33.

"Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression".

Muth M, Theophile K, Hussein K, Jacobi C, Kreipe H, Bock O.

J Transl Med. 2010 Apr 1;8:33. doi: 10.1186/1479-5876-8-33. Erratum in: J Transl Med. 2011;9:24.

34.

Swallow-tail substituted liquid crystalline perylene bisimides: synthesis and thermotropic properties.

Wicklein A, Lang A, Muth M, Thelakkat M.

J Am Chem Soc. 2009 Oct 14;131(40):14442-53. doi: 10.1021/ja905260c.

PMID:
19764754
35.

Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.

Bock O, Muth M, Theophile K, Winter M, Hussein K, Büsche G, Kröger N, Kreipe H.

Br J Haematol. 2009 Sep;146(5):510-20. doi: 10.1111/j.1365-2141.2009.07808.x. Epub 2009 Jul 13.

PMID:
19604240
36.

Certified kitchen managers: do they improve restaurant inspection outcomes?

Cates SC, Muth MK, Karns SA, Penne MA, Stone CN, Harrison JE, Radke VJ.

J Food Prot. 2009 Feb;72(2):384-91.

PMID:
19350984
37.
38.

Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.

Bolaños-Meade J, Luznik L, Muth M, Matsui WH, Huff CA, Smith BD, Levy MY, Kasamon YL, Swinnen LJ, Powell JD, Brodsky RA, Ambinder RF, Jones RJ, Fuchs EJ.

Bone Marrow Transplant. 2009 Mar;43(6):477-80. doi: 10.1038/bmt.2008.353. Epub 2008 Nov 3.

39.

Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity.

Antony J, Kellershohn K, Mohr-Andrä M, Kebig A, Prilla S, Muth M, Heller E, Disingrini T, Dallanoce C, Bertoni S, Schrobang J, Tränkle C, Kostenis E, Christopoulos A, Höltje HD, Barocelli E, De Amici M, Holzgrabe U, Mohr K.

FASEB J. 2009 Feb;23(2):442-50. doi: 10.1096/fj.08-114751. Epub 2008 Oct 8.

PMID:
18842964
40.

Genomic characterisation, chromosomal assignment and in vivo localisation of the canine high mobility group A1 (HMGA1) gene.

Beuing C, Soller JT, Muth M, Wagner S, Dolf G, Schelling C, Richter A, Willenbrock S, Reimann-Berg N, Winkler S, Nolte I, Bullerdiek J, Murua Escobar H.

BMC Genet. 2008 Jul 23;9:49. doi: 10.1186/1471-2156-9-49.

41.

[Chronic obstructive pulmonary disease].

Holzgrabe U, Muth M.

Med Monatsschr Pharm. 2007 May;30(5):168-76; quiz 177-8. Review. German.

PMID:
17526393
42.

Antitrypanosomal activity of quaternary naphthalimide derivatives.

Muth M, Hoerr V, Glaser M, Ponte-Sucre A, Moll H, Stich A, Holzgrabe U.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1590-3. Epub 2007 Jan 4.

PMID:
17239596
43.

Partnering with patients and families in designing visual cues to prevent falls in hospitalized elders.

Jeske L, Kolmer V, Muth M, Cerns S, Moldenhaur S, Hook ML.

J Nurs Care Qual. 2006 Jul-Sep;21(3):236-41.

PMID:
16816604
44.

Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.

Disingrini T, Muth M, Dallanoce C, Barocelli E, Bertoni S, Kellershohn K, Mohr K, De Amici M, Holzgrabe U.

J Med Chem. 2006 Jan 12;49(1):366-72.

PMID:
16392821
45.

Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.

Muth M, Sennwitz M, Mohr K, Holzgrabe U.

J Med Chem. 2005 Mar 24;48(6):2212-7.

PMID:
15771463
46.

Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding.

Muth M, Bender W, Scharfenstein O, Holzgrabe U, Balatkova E, Tränkle C, Mohr K.

J Med Chem. 2003 Mar 13;46(6):1031-40.

PMID:
12620079
47.

Polyethylene-based water-equivalent phantom material for x-ray dosimetry at tube voltages from 10 to 100 kV.

Hermann KP, Geworski L, Muth M, Harder D.

Phys Med Biol. 1985 Nov;30(11):1195-200.

PMID:
4080819
48.

[Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].

Pullmann H, Muth M.

Z Hautkr. 1982 Feb 15;57(4):294-7. German. No abstract available.

PMID:
7080583

Supplemental Content

Support Center